Skip to content
MANA

Specialty 2

MANA LASE DX

FDA cleared indication: Placeholder FDA cleared-indication language for Device 2. The only indication language used on /us/.

The opportunity

Placeholder §6.1 for Device 2: the clinic's reality and revenue logic — the opportunity in their business, not our specs.

What wins clients

Placeholder §6.2 for Device 2: faster, less painful, longer-lasting — why patients choose one clinic over another.

The regenerative layer

Placeholder §6.3 for Device 2: the multilayer regeneration framing relevant to this device; links to The MANA approach.

The MANA approach — our regeneration framework

Our device — the answer

Placeholder §6.4 for Device 2: the device introduced as the embodiment of the opportunity, what wins clients, and the regenerative layer.

MANA LASE DX

Proof in their terms

Placeholder §6.5 for Device 2: ROI, durability, throughput, consumable economics in the clinician's terms.

Spec A
Value A2
Spec B
Value B2
Spec C
Value C2

Peer testimonials

If you're considering Plasma at all, and you have the financial resources to bring this into your practice, it is a decision you will not regret.

Dr. Chris Croley, MD

Skin & Tonic Med Spa, City 2

ROI in 8 months

Individual results may vary.

Device 2 · MANA Regenerative Biotech · MANA Regenerative Biotech